[PDF] Top 20 Multiple Myeloma associated Bone Disease
Has 10000 "Multiple Myeloma associated Bone Disease" found on our website. Below are the top 20 most common "Multiple Myeloma associated Bone Disease".
Multiple Myeloma associated Bone Disease
... lytic bone disease is a hallmark of multiple myeloma, being present in about 80% of patients with newly diagnosed MM, and in more during the disease ...The myeloma ... See full document
24
A mathematical model of bone remodeling dynamics for normal bone cell populations and myeloma bone disease
... of myeloma bone disease. Multiple myeloma is a hematolog- ical malignancy associated with clonal expansion of malignant plasma cells within the bone ...of myeloma ... See full document
17
Original Article Anti-myeloma properties and mechanism of polymethyl methacrylate bone cement and allograft bone in vitro
... with multiple myelo- ma has been prolonged ...of disease progression [4, ...plus bone defect fillers, and plate internal fixation. PMMA bone cement and allograft bone are widely used in ... See full document
6
Soluble Rank Ligand Produced by Myeloma Cells Causes Generalised Bone Loss in Multiple Myeloma
... trabecular bone in 5T2MM bearing mice compared to non-tumour bearing, naı¨ve mice (Figure 4A and 4B), although, bone loss was also associated with significant infiltration of 5T2MM tumour ... See full document
10
Centrosome associated genes pattern for risk sub stratification in multiple myeloma
... of disease at clin- ical level. It seems that there are several “myeloma sub- groups” which differ in expression profile and in clinical manifestations, ... See full document
9
MULTIPLE MYELOMA A new era for an old disease
... Multiple myeloma (MM) is the second most common hematologic malignancy, after non-Hodgkin’s lym- ...including bone pain and fractures, fatigue, neuropathy and recurrent infec- ...the bone ... See full document
6
Micro-RNAs, New performers in multiple myeloma bone marrow microenvironment
... cells?, does it happen due to influence of some cytokines/ mediators released by BMSCs?, is the altered expression of miRs in MM cell-BMSC co-cultures a function of co-operative interaction (miR change in both cell ... See full document
6
Identification of miRSNPs associated with the risk of multiple myeloma.
... Multiple myeloma (MM) is a malignancy of plasma cells, usually infiltrating the bone marrow, and associated with the production of a monoclonal immunoglobulin (M protein) which can be detected ... See full document
25
Multiple myeloma associated with IgA lambda gammopathy and multiple myeloma oncogene 1 in a Yorkshire terrier
... 10% bone marrow plasmacy- tosis is conventionally required to diagnose MM, the proportion of bone marrow plasma cells was ...of bone marrow specimens from an osteolytic lesion to confirm ... See full document
6
The non-peptide thrombopoietin receptor agonist eltrombopag stimulates megakaryopoiesis in bone marrow cells from patients with relapsed multiple myeloma
... human myeloma cells via c-mpl- independent pathways, either alone or in combination with other hematopoietic growth factors such as granulo- cyte colony-stimulating factor (G-CSF) and erythropoietin (EPO), which ... See full document
11
Tapentadol prolonged release for patients with multiple myeloma suffering from moderate-to-severe cancer pain due to bone disease
... Cancer patients are currently treated mainly with tradi- tional strong opioids according to the World Health Orga- nization analgesic ladder. However, it is well known that neuropathic pain is relatively poorly ... See full document
10
Obstructive Jaundice as Initial Presentation of Multiple Myeloma: Case Presentation and Literature Review
... with multiple myeloma. However, one cannot simply hold multiple myeloma accountable for elevated liver enzymes in patients with multiple ...in multiple myeloma than any ... See full document
5
Bortezomib resistance in multiple myeloma is associated with increased serine synthesis
... of multiple mye- loma patients isolated either at diagnosis, during therapy or after relapse from various therapeutic interventions ...metastatic disease prior to therapy, PHGDH expression was ... See full document
12
Prevalence of bisphosphonate associated osteonecrosis of the jaws in multiple myeloma patients
... The second study had a cross sectional design and was conducted in the Department of Haematology and Oncology at the Johannes Gutenberg-University Mainz, Germany. All 78 patients with multiple myeloma ... See full document
8
FIFTEEN YEARS OF SINGLE CENTER EXPERIENCE WITH STEM CELL TRANSPLANTATION FOR MULTIPLE MYELOMA: A RETROSPECTIVE ANALYSIS
... Multiple myeloma is the second most frequent hemato- logic malignancy responsible for about 86,000 new cases worldwide each year ...symptomatic disease is char- acterised by the presence of increased ... See full document
5
Molecular pathogenesis of multiple myeloma and its premalignant precursor
... Multiple myeloma (MM) is an age-dependent monoclonal tumor of BM plasma cells ...is associated with end-organ damage that can include lytic bone lesions, anemia, immunodeficiency, and ... See full document
9
Imaging Findings of Plasmacytoma of Both Breasts as a Preceding Manifestation of Multiple Myeloma
... time, bone marrow aspira- tion revealed less than 10% plasma cells and there was no evidence of bony involvement or end-organ ...the disease had been in ...the disease to nearly the entire body ... See full document
6
Methods Study Design: Descriptive study Study Population: Study sample includes all the cases of multiple myeloma received in the Department
... Bone marrow examination provides variable information about plasma cell morphology which helps in determining the prognosis of the disease. Cytoplasmic kappa and lambda light chain is useful in ... See full document
9
Identification of malignant plasma cell precursors in the bone marrow of multiple myeloma
... In multiple myeloma, the CALLA+ cells were negative for surface and cytoplasmic immunoglobulins (Ig), and, unlike CALLA+, terminal deoxynucleotidyl transferase (TdT+) pre-B cells in the normal bone ... See full document
10
LIGHT/TNFSF14 increases osteoclastogenesis and decreases osteoblastogenesis in multiple myeloma-bone disease
... Furthermore, we investigated LIGHT pro- osteoclastogenic effect using cultures of PBMCs or CD14+ monocytes from the healthy-donors, where LIGHT dose-dependently increased the OC formation rate. This finding was amplified ... See full document
18
Related subjects